Novel etodolac derivatives as eukaryotic elongation factor 2 kinase (eEF2K) inhibitors for targeted cancer therapy

Ferah Comert Onder, Pinar Siyah, Serdar Durdagi, Mehmet Ay, Bulent Ozpolat

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Novel etodolac derivatives as eukaryotic elongation factor 2 kinase (eEF2K) inhibitors for targeted cancer therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry